0.03Open0.03Pre Close10 Volume0 Open Interest7.50Strike Price30.00Turnover377.84%IV302.67%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier14DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.0646Delta0.0917Gamma62.33Leverage Ratio-0.0060Theta0.0000Rho4.03Eff Leverage0.0005Vega
aTyr Pharma Stock Discussion
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
Post hoc analysis of Phase 1b/2a study demonstrated statistically significant difference in time-to-first-relapse for corticosteroid use in therapeutic (3.0 and 5.0 mg/kg efzofitimod) vs subtherapeutic (1.0 mg/kg efzofitimod and placebo) groups.
54.4% of patients in the subtherapeutic group relapsed following corticosteroid taper, compar...
No comment yet